Brind.

FDA Issues Alert Over Device Issue in Edwards Lifesciences Procedure

2 reports, 2 independent Updated Mon 00:00
No new developments lately
Reports
2
Developments
2
Repetition
0%

New informationRepeats or wire copies

AI-generated briefing. Brind wrote this from the reports listed below and has updated it as the story developed. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

The FDA issued a safety notification concerning delivery systems used in Edwards Lifesciences’ Sapien M3 transcatheter mitral valve replacement procedure. This alert followed reports of three balloon bursts during inflation, which included one death and one serious injury. Edwards Lifesciences advised customers to stop using and return four specific lot numbers of the Commander M delivery system.

From ocbj.com, medicaldaily.com

Why it matters

Some supportBrind's analysis of the reports

The device failure and subsequent product removal create regulatory risk for Edwards Lifesciences. Following the alert, shares in Edwards decreased 1.3% to $86.94.

From ocbj.com

Who's involved

  • FDARegulatory agency that issued the safety notification and Early Alert.
  • Edwards LifesciencesMedical technology company whose delivery system was subject to the FDA alert.

Who could feel it

Possible knock-on effects

These are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.

  • Edwards LifesciencesSpeculative

    Edwards Lifesciences could face increased costs and decreased revenue due to the required product recall.

  • Royal Bank of CanadaSpeculative

    Royal Bank of Canada might adjust investment ratings or targets for the company following the negative event.

Possible ripples

Who this could reach next, traced step by step from the reporting. Possibilities worth considering, not forecasts.

How it developed

Newest first. Tap a step to see who reported it.
  1. FDA issued a safety notification regarding delivery systems involving Edwards.1 source
  2. FDA issued an Early Alert concerning a device issue at Edwards Lifesciences.1 source

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped